Science Explorer Back to mapMap
Discussion
Researcher · Centre Léon Bérard · France

Clélia Coutzac

Clélia Coutzac publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies and Gastric Cancer Management and Outcomes.

ORCID 0000-0002-8347-6957 OpenAlex
World rank
#560,569
of 7,710,434 ranked researchers
Rank in France
#28,752
of 324,115
Works
111
Citations
3.9k
Citations per work
35.2
h-index
20
i10-index 29Top 23% in Oncology
Clélia Coutzac

What does Clélia Coutzac research?

Clélia Coutzac's work is mostly in Medicine (75%), Biochemistry, Genetics and Molecular Biology (4%).

Health Sciences: 83 works · 75.1% of their workMedicine: 83 works · 75.1% of their workOncology: 42 works · 37.8% of their workPulmonary and Respiratory Medicine: 20 works · 18.0% of their workSurgery: 10 works · 8.7% of their workEpidemiology: 6 works · 5.6% of their workPathology and Forensic Medicine: 6 works · 5.0% of their workEverything else: 23 works · 20.6% of their workLife Sciences: 5 works · 4.3% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 4.3% of their workCancer Research: 5 works · 4.3% of their workTHEIR WORKClélia Coutzac111works
Life Sciences4%Health Sciences75%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine8375.1%
  2. Everything else2320.6%
    1. Biochemistry, Genetics and Molecular Biology54.3%
  1. 1Oncology38% of their works
  2. 2Pulmonary and Respiratory Medicine18% of their works
  3. 3Surgery9% of their works
  4. 4Epidemiology6% of their works
  5. 5Pathology and Forensic Medicine5% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe Clélia Coutzac's research?

The keywords of their largest research topics: Chemotherapy, Immune Checkpoint Blockade, PD-1 and PD-L1, Molecular Characterization, Cetuximab, KRAS Mutations, Endoscopic Resection and Gastric Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Chemotherapy663 topics
  2. Immune Checkpoint Blockade471 topic
  3. PD-1 and PD-L1471 topic
  4. Molecular Characterization412 topics
  5. Cetuximab301 topic
  6. KRAS Mutations301 topic
  7. Endoscopic Resection251 topic
  8. Gastric Cancer251 topic
  9. Breast Cancer222 topics
  10. Targeted Therapy222 topics
  11. Hereditary Syndromes161 topic
  12. Microsatellite Instability161 topic
  13. ALK Inhibitors121 topic
  14. EGFR Mutations121 topic
  15. CDK4/6 Inhibitors111 topic
  16. HER2111 topic
  17. Palbociclib111 topic
  18. Trastuzumab111 topic
  19. Cancer Genomics101 topic
  20. Mutational Signatures101 topic

Where does Clélia Coutzac work?

Clélia Coutzac's main affiliation in the publication record is Centre Léon Bérard, France.

How many publications and citations does Clélia Coutzac have?

OpenAlex counts 111 works and 3,906 citations for Clélia Coutzac, an h-index of 20, ranking #560,569 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Clélia Coutzac. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.